Question 1

How many shares of XLO does BALYASNY ASSET MANAGEMENT L.P. own?

Accepted Answer

BALYASNY ASSET MANAGEMENT L.P. previously held 0 shares of XLO (XILIO THERAPEUTICS INC) before exiting the position in 2025-Q4.

Question 2

What is BALYASNY ASSET MANAGEMENT L.P.'s XLO position worth?

Accepted Answer

BALYASNY ASSET MANAGEMENT L.P.'s XLO position was last reported at $0 in 2025-Q4 before the exit.

Question 3

Is BALYASNY ASSET MANAGEMENT L.P. buying or selling XLO?

Accepted Answer

In 2025-Q4, BALYASNY ASSET MANAGEMENT L.P. exited their XLO position entirely (-100.0% change in shares).

Question 4

When did BALYASNY ASSET MANAGEMENT L.P. first buy XLO?

Accepted Answer

Based on available 13F filings, BALYASNY ASSET MANAGEMENT L.P. first reported a position in XLO in 2024-Q3. They have held the position across 8 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$0.65	0
2025-Q3	Unchanged	198,859	0.0%	$167,578	0.0%	$0.86	0
2025-Q2	Decreased	198,859	-21.8%	$135,204	0.0%	$0.68	0
2025-Q1	Decreased	254,346	-25.9%	$184,248	0.0%	$10.14	0
2024-Q4	Increased	343,230	+26.0%	$327,785	0.0%	$0.97	29
2024-Q3	Unchanged	272,486	0.0%	$214,637	0.0%	$0.76	0